Lokken Investment Group’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $324K | Sell |
1,746
-8
| -0.5% | -$1.49K | 0.12% | 103 |
|
|
2025
Q1 | $367K | Buy |
1,754
+6
| +0.3% | +$1.26K | 0.16% | 91 |
|
|
2024
Q4 | $311K | Buy |
1,748
+2
| +0.1% | +$355 | 0.13% | 100 |
|
|
2024
Q3 | $345K | Buy |
1,746
+19
| +1% | +$3.75K | 0.14% | 104 |
|
|
2024
Q2 | $296K | Buy |
1,727
+59
| +4% | +$10.1K | 0.14% | 109 |
|
|
2024
Q1 | $304K | Buy |
1,668
+2
| +0.1% | +$364 | 0.15% | 102 |
|
|
2023
Q4 | $258K | Buy |
1,666
+58
| +4% | +$8.99K | 0.15% | 107 |
|
|
2023
Q3 | $240K | Sell |
1,608
-80
| -5% | -$11.9K | 0.16% | 109 |
|
|
2023
Q2 | $227K | Sell |
1,688
-153
| -8% | -$20.6K | 0.15% | 113 |
|
|
2023
Q1 | $293K | Sell |
1,841
-42
| -2% | -$6.69K | 0.22% | 97 |
|
|
2022
Q4 | $304K | Buy |
1,883
+3
| +0.2% | +$485 | 0.24% | 92 |
|
|
2022
Q3 | $252K | Buy |
1,880
+4
| +0.2% | +$536 | 0.22% | 96 |
|
|
2022
Q2 | $287K | Buy |
1,876
+4
| +0.2% | +$612 | 0.23% | 92 |
|
|
2022
Q1 | $275K | Buy |
1,872
+4
| +0.2% | +$588 | 0.22% | 102 |
|
|
2021
Q4 | $253K | Buy |
+1,868
| New | +$253K | 0.18% | 111 |
|